Skip to main content
Log in

Determination of 5,5-diphenylhydantoin and its major metabolites in biological specimens by gas chromatography and selected ion-monitoring

  • Originals
  • Published:
Chromatographia Aims and scope Submit manuscript

Summary

A specific and sensitive procedure for simultaneous determination of 5,5-diphenylhydantoin, 5-(4-hydroxyphenyl)-5-phenylhydantoin, 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin and 5-(3-methoxy-4-hydroxyphenyl)-5-phenylhydantoin in biological specimens is described. The method involves formation of butylated or trideuteromethylated derivatives of the drug and its metabolites and analysis by gas chromatography. The lower detectable concentration of these compounds per ml of body fluids or g of wet tissue is either 1 μg or 20 ng, depending on the type of detector used, flame ionization or selected-ion monitoring. Data on the urinary elimination of 5,5-diphenylhydantoin and hydroxylated metabolites in male rats following a single intraperitoneal injection of the drug (25 mg/kg) are also reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. J. Laidlaw, A. Richens (Editors), A text-book of Epilepsy, Churchill, Edinburgh, 1976.

    Google Scholar 

  2. S. I. Johannessen, P. L. Morselli, C. E. Pippenger, A. Richens, S. Schmidt, H. Meinardi (Editors). Antiepileptic Therapy: Advances in Drug Monitoring, Raven Press, New York, 1980.

    Google Scholar 

  3. A. J. Glazko, Drug Metab. Dispos.1, 711 (1973).

    Google Scholar 

  4. W. A. Dill, A. Kazenko, L. M. Wolf, A. J. Glazko, J. Pharmacol. Exp. Ther.118, 270 (1956).

    Google Scholar 

  5. W. A. Dill, A. J. Glazko, Clin. Chem.18, 675 (1972).

    Google Scholar 

  6. D. H. Sandberg, G. L. Resnick, C. Z. Bacallao, Anal. Chem.40, 736 (1968).

    Google Scholar 

  7. G. Grimmer, J. Jacob, H. Schafer, Arzneim. Forsch.19, 1287 (1969).

    Google Scholar 

  8. J. McGee, Anal. Chem.42, 421 (1970).

    Google Scholar 

  9. H. J. Kupferberg, Clin. Chem. Acta29, 282 (1970).

    Google Scholar 

  10. P. M. Kabra, B. E. Stafford, L. J. Marton, Clin. Chem.23, 1284 (1977).

    Google Scholar 

  11. M. G. Horning, C. M. Butler, J. Nowlin, K. Lertratanangkoon, T. E. Zion, P. Kellaway, R. M. Hill, inA. Rickens, F. P. Woodford (Editors), Anticonvulsivant Drugs and Enzyme Induction, Elsevier, Amsterdam, 1976, p. 61.

    Google Scholar 

  12. M. G. Horning, C. M. Butler, K. Lertratanangkoon, R. M. Hill, T. E. Zion, P. Kellaway, inP. Kellaway, I. Petersen (Editors), Quantitative Analytic Studies in Epilepsy, Raven Press, New York, 1976, p. 95.

    Google Scholar 

  13. M. Arboix, C. Pantarotto, in 39th International Congress of Pharmaceutical Sciences, Brighton, September 3–7, 1979, abstract no. 100.

  14. G. Lhoëst, J. H. Poupaert, M. Claesen, Eur. J. Mass Spectrom. Biochem. Med. Environ. Res.1, 57 (1980).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arboix, M., Pantarotto, C. Determination of 5,5-diphenylhydantoin and its major metabolites in biological specimens by gas chromatography and selected ion-monitoring. Chromatographia 15, 509–513 (1982). https://doi.org/10.1007/BF02260285

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02260285

Key Words

Navigation